New robotics platform for accelerated antibiotic development
Leibniz-HKI and Analytik Jena develop facility for automated testing of drug candidates
(c) Anna Schroll/Leibniz-HK
The antibiotics crisis is one of the greatest medical challenges of our time. Increasing resistance means that people are once again dying from bacterial infections that were long considered to be easily treatable.
At the same time, the pharmaceutical industry has largely withdrawn from the less profitable development of new antibiotics. A major reason for this is lack of profitability: antibiotics are used sparingly, sold at low prices, and also have short treatment durations.
Publicly funded research is trying to close this gap. "As a state, we provide targeted support for application-oriented research in order to take the results all the way to value creation in Thuringia," said Katja Böhler, State Secretary for Research, Innovation and Economic Development at the Thuringian Ministry of Economic Affairs, Science and Digital Society. She referred in particular to the innovation umbrella program "Thuringia MOTIVation," which bundles all related funding instruments. "Future-oriented cooperation between science and industry makes Jena and Thuringia a high-tech location with many highly qualified jobs. The new robotics facility is an example of how well this interplay between public and private players works here in the state."
"Antibiotic development with the help of public research funding is a major challenge that our institute is taking on," says Pierre Stallforth, deputy director and project leader of the new robotics platform at Leibniz-HKI. This was achieved most recently with the tuberculosis agent BTZ-043, which was discovered at Leibniz-HKI and further developed in cooperation with academic partners and industry.
In the future, the new robotics platform set up at the HKI Biotech Center should be able to perform experiments faster and more accurately, as repetitive steps are always carried out in exactly the same way. "The combination of automation, data analysis and innovative research approaches increases the chances of success in identifying new antibiotics," explains Luzia Gyr, head of the facility.
The technology platform was designed in close development cooperation with Analytik Jena. The most important requirement of the future users was that the system should be as flexible as possible. "Industrial plants are normally characterized by a fixed process sequence. Here we have a platform that is equipped for the future and can respond to the high variability of the research topics of the institute and its partners," explains Matthias Fischer, team leader of automation at Analytik Jena. And Lars Böttcher, Vice President of Technology at Analytik Jena, adds: "The project was technically very demanding, but due to the short distances and the very intensive coordination of all participants directly on site, it could be realized in a relatively short time."
The construction of the modern facility was only made possible by extensive public funding. It was largely funded by the German Federal Ministry of Education and Research as part of the Zwanzig20 consortium InfectControl and its follow-up projects. Additional funding was provided by the German Research Foundation as part of the Balance of the Microverse cluster of excellence and by the state of Thuringia with money from the European Regional Development Fund (ERDF). The total volume of the investment is three million euros. In addition, the Free State of Thuringia is funding the RoboThür research group, which has applied jointly with the Friedrich Schiller University of Jena, with one million euros, thus enabling the recruitment of highly qualified personnel for the platform.
The new robotics platform will not only be available to the Leibniz-HKI research groups, but also to the University of Jena and other research institutions and industrial partners with which the institute cooperates. The commissioning of the system, which has just taken place, will now be followed by a phase of setting up the first test series and validating the results, which will take several months.
Other news from the department research and development
UK approves world's first therapy with gene scissors
Developers of the Crispr method were awarded the Nobel Prize in 2020: a drug using the gene scissors has now been approved for the first time
Novel protein to prevent immune system attacks on own body
1.2 million euros for immunology start-up
Startup HyPhoX develops miniaturized biosensors with support from BAM
"The innovative thing about our sensor is that we combine optical, electrical and biochemical analytics on one chip, and we do it in a handy, portable device"
Collaboration to develop vaccine against Helicobacter pylori
Core Facility Animal Models and start-up company Iguana cooperate
Fraunhofer IPA transfers rights to use laboratory robot KEVIN United Robotics Group
KEVIN can be flexibly and intuitively integrated into laboratory infrastructures and automates processes
Dresden-based start-up "DermaPurge" develops skin cleanser for hazardous substances
Global Handwashing Day
SAS accelerates delivery of novel medicines using AI and analytics
Cooperation with AstraZeneca for more innovation in clinical research
New incubator to promote drug discovery and create new therapeutics companies in Singapore
Evotec, ClavystBio, Leaps by Bayer, Lightstone Ventures and Polaris Partners launch "65LAB"
Groundbreaking: Takeda builds lab of the future in Vienna
New research and development laboratory in Vienna's Donaustadt district
New muscle therapy gets fast-track boost
Berlin start-up could soon be helping children with previously incurable muscle diseases thanks to an accelerated approval process
‘Human Inks’ for 3D Printing of Human Tissues
Animal Free 3D Bioprintin: HU3DINKS Project Brings Together Expert Companies
Cell therapy meets the very latest in gene editing: start-up Cimeio joins forces with Prime Medicine
Repairs within the body: The start-up wants to make blood stem cell transplants easier on the body
New biotech venture PHIOGEN to tackle the global threat of antimicrobial resistance
By optimizing nature’s defenders, the team has produced unprecedented phage treatments
Waters Corporation and Princeton University Announce Multi-Year Research Collaboration
Agreement to take on real-world challenges in biologics and materials research
Bioprinting of Highly Complex Structures Now Possible
Cooperation of UpNano and BIO INX yields further advancement: Two-stage 3D-printing of organ-on-chip devices with encapsulated live cells is possible
Novel insights into one's own body via smartphone
trinamiX is working on previously impossible smartphone features
Most read news
Bowel cancer: aspirin activates protective genes
Researchers have identified a signaling pathway by which aspirin can inhibit colorectal cancer.
New drug delivery system could reduce daily diabetes shots to just three a year
Dietary management drugs have transformed Type 2 diabetes care, but daily injection routines are challenging for some patients
How stem cells and immune cells communicate
Lisec Artz Award for Simon Haas: Groundbreaking discovery of an unknown protective mechanism against blood cancer from stem cells
The weight of pollution: exposure linked to obesity
Chronic exposure to environmental pollutants found to increase risk of cardiovascular disease
Textbook knowledge turned on its head: 3-in-1 microorganism discovered
Newly multifunctional bacterial species
Plants transformed into detectors of dangerous chemicals
Scientists engineer plants to speak in color
Plastic-eating bacteria turn waste into useful starting materials for other products
Microbial Upcycling of Waste PET
Breakthrough Discovery Sheds Light on Heart and Muscle Health
Scientists shoot first true-to-life 3D image of the thick filament of mammalian heart muscle
More news from our other portals
New designs for solid-state electrolytes may soon revolutionize the battery industry
Scientists achieve monumental improvements in lithium-metal-chloride solid-state electrolytes
Eating grasshoppers and mealworms - yuck
European research project investigated the acceptance of insects as food in three countries
Aston University technology to combat the not-so sweet practice of honey fraud
Light technology to be used to detect if honey is blended with cheap additions
Dow and Evonik announce startup of hydrogen peroxide to propylene glycol (HPPG) pilot plant
Innovative technology offer flexibility, lower costs, and a smaller environmental footprint
Autonomous measuring instruments systematically detect new materials
A new algorithm measures materials libraries up to four times faster than before: It’s based on machine learning
This is a battery
Two colored liquids bubbling through tubes: Is this what the battery of the future looks like?
Converting PFAS “forever chemicals” into valuable compounds
Scientists develop a new method to incorporate harmful perfluoroalkenes into N-heterocyclic carbene ligands
Researchers discover new ultra strong material for microchip sensors
A material that doesn't just rival the strength of diamonds and graphene, but boasts a yield strength 10 times greater than Kevlar
Inauguration of the world’s first pilot plant for the cost-efficient production of green methanol
Start-up C1 Green Chemicals AG and research partners develop fundamentally new production process
Naked Clams: The New Superfood Sensation Emerging from the Depths
Researchers found Naked Clams contain almost twice the amount of Vitamin B12 as blue mussels and have developed an efficient way to farm them
Graphene's proton permeability: A switch for future energy technologies
This discovery could lead to the development of more efficient hydrogen fuel cells and solar water-splitting devices
Ritter Sport Vegan with new variety Crispy Cookie
If you like crunch, you'll love this novelty: Starting in January, Ritter Sport is launching Crispy Cookie, a new vegan variety.
‘Hot’ new form of microscopy examines materials using evanescent waves
“This microscope technology is completely new, so we’re still learning specifically how and where it can be applied”
Electromobility: New early warning system to provide better protection against burning lithium-ion batteries
New system measures and analyzes impedance
Lithium-ion batteries are no longer the gold standard in battery tech
On the way to safer and more powerful energy sources
Pushers, overcrowded trains and phone zombies
Sprite presents the world's first vending machine that responds to the things that bother Generation Z the most
Technology Group STRABAG invests € 100 million into battery and energy storage company CMBlu Energy
The ideal combination of technological and construction industry expertise to advance energy transition
thyssenkrupp Uhde awarded contract by ENOWA to supply a green methanol and methanol-to-gasoline plant
CO2-to-methanol and methanol-to-gasoline demonstration plant to supply synthetic fuels for various applications in the light duty transport sector